Core Scientific had its Relative Strength (RS) Rating upgraded from 90 to 96 Friday.
How To Use Stock Charts To Stay Profitable And Protected
IBD's unique RS Rating identifies technical performance by showing how a stock's price movement over the last 52 weeks compares to that of the other stocks in our database.
Over 100 years of market history reveals that the best stocks tend to have an RS Rating of above 80 in the early stages of their moves.
Core Scientific has risen more than 5% past a 12.25 entry in a second-stage consolidation, meaning it's now out of a proper buy range. Look for the stock to offer a new chance to get in like a three-weeks tight or pullback to the 50-day or 10-week line.
Earnings growth increased last quarter from 0% to 60%. But sales fell from -33% to -56%.
Core Scientific earns the No. 26 rank among its peers in the Financial Services-Specialty industry group. X Financial ADR, Jiayin Group ADR and Marex Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
